In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Subscribe To Our Newsletter & Stay Updated
